PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.
Click the orange button to the right to learn more.
This guide explains what melanoma survivors need to know after treatment ends.
Okay, I’m a survivor of a blood cancer, not melanoma. However I did undergo an autologous stem cell transplant that increases my risk of melanoma. And I’ve had a couple of moles removed. One removal was “inconclusive” and one came back as “basel cell carcinoma.” So I am hypervigilant about all types of skin cancer including a formal diagnosis of melanoma.
Are you a melanoma survivor? Let me know. If you want to learn more about melanoma survivorship, watch the video below. Wow…
Good luck,
Cancer survivorship begins at diagnosis and continues throughout life. For melanoma survivors, follow-up care remains essential because melanoma can recur years—even decades—after initial treatment. Survivors also face an increased risk of developing a second melanoma.
Research shows that while most recurrences occur within the first 2–5 years, late recurrences more than 10 years after treatment are well documented. Additionally, melanoma survivors have a higher risk of developing another primary melanoma compared with the general population.
The goals of melanoma follow-up include:
Studies indicate that recurrence risk is highest during the first five years after treatment, although ongoing surveillance remains important throughout life. Recurrences may occur locally, in lymph nodes, or in distant organs. Many are first detected through physical examination or patient self-monitoring.
Your exact follow-up schedule depends on your original melanoma stage, treatment history, and overall health.
Typical recommendations include:
Routine imaging is generally not recommended unless symptoms develop.
Follow-up often includes:
Higher-risk Stage IIB and IIC patients may undergo periodic CT, PET/CT, or MRI surveillance.
Patients with advanced melanoma typically require:
Many experts recommend continued surveillance for at least five years, with individualized follow-up thereafter.
Research suggests that many melanoma recurrences are first detected by patients themselves.
Contact your healthcare team if you notice:
Early detection remains one of the most effective ways to improve outcomes.
A monthly skin examination should become part of every survivor’s routine.
Use mirrors to examine:
Remember the ABCDE warning signs:
Photographs can help track changes over time.
Although melanoma can recur independently of sun exposure, ultraviolet damage remains a major risk factor for developing new melanomas.
Recommended strategies include:
Sun protection should become a lifelong habit.
Many melanoma survivors experience lingering effects from treatment.
Possible issues include:
Physical therapy may help improve function and quality of life.
Checkpoint inhibitors such as nivolumab and pembrolizumab have transformed melanoma survival but may create long-term immune-related complications.
Potential effects include:
Some side effects may require lifelong monitoring.
Many survivors experience:
Support groups, counseling, mindfulness training, and exercise programs may improve psychological well-being.
Physical activity offers numerous benefits:
General recommendations include:
Start slowly if treatment-related fatigue remains significant.
No diet can guarantee prevention of melanoma recurrence, but evidence supports a healthy dietary pattern that promotes overall wellness.
Focus on:
Limit:
Maintaining a healthy weight may reduce chronic inflammation and improve survivorship outcomes.
Research demonstrates that melanoma survivors face an elevated risk of developing another primary melanoma.
Because of this increased risk:
Long-term vigilance is essential.
Survival rates continue to improve. Modern immunotherapy has dramatically changed outcomes for advanced melanoma, with some long-term studies reporting survival beyond 10 years for many patients.
As survivorship increases, attention is shifting toward:
The goal is no longer simply surviving melanoma—but thriving after it.
The end of treatment is not the end of your melanoma journey. Survivorship is an ongoing process of monitoring, prevention, recovery, and living well.
Link naturally to existing or future PeopleBeatingCancer content such as: